Daicel Targets 2024 for Launch of Centralized Medical Business Jan. 17, 2022 Filed Under: Pharma Tagged With: Daicel, health care, medical, restructuring, strategyDaicel Corp. (TYO:4202) is making preparations to launch a medical business for 2024. On top of bringing together the handling…... Please subscribe to read the full story. Subscribe Free Trial Related Articles:Daicel Director Hisao Nishimura Talks Efforts in Five New…Daicel Aims High With Plans for Substantial Energy SavingsColumn: Daicel Looks to Transform Corporate Group MakeupDaicel Aims to Shore up Cellulose Acetate Business With…Daicel Eyes Plans to Move to Holding System in Spring 2021Daicel Set to Offer Marine Biodegradable Plastic Sheets